Renal cancers are estimated about 2-3% of all worldwide human cancers and over 90% of renal cancers are renal cell carcinomas (RCCs). Treatment options chosen by urologists are based on oncological and quality of life outcomes. Surgical resection remains the effective option for localized and advanced RCC. The definite consensus of follow-up guideline is not yet established because of heterogen…